Fort Baker Capital Management’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Fort Baker Capital Management’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-36,934	Closed	-$2.61K	–	85
2024 Q3	$2.61K	Hold	36,934	–	–	﹤0.01%	73
2024 Q2	$3.65K	Hold	36,934	–	–	﹤0.01%	77
2024 Q1	$5.91K	Hold	36,934	–	–	﹤0.01%	72
2023 Q4	$2.98K	Buy	+36,934	New	+$4.98K	﹤0.01%	83
2023 Q3	–	Sell	-36,934	Closed	-$7.74K	–	103
2023 Q2	$7.74K	Hold	36,934	–	–	﹤0.01%	91
2023 Q1	$5.17K	Hold	36,934	–	–	﹤0.01%	93
2022 Q4	$3.14K	Sell	36,934 -18,464	-33%	-$1.55K	﹤0.01%	84
2022 Q3	$8K	Hold	55,398	–	–	﹤0.01%	106
2022 Q2	$15K	Hold	55,398	–	–	﹤0.01%	104
2022 Q1	$537K	Buy	+55,398	New	+$46.1K	0.08%	46

Other funds holding NKGNW

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Fort Baker Capital Management's NKGNW Position: Q4 2024 in Review

Fort Baker Capital Management sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q4 2024, closing a stake of 36,934 shares — an estimated $2.61K sold.

Fort Baker Capital Management first reported a position in NKGNW in Q1 2022 and held it in 10 quarters. The position peaked at $537K in Q1 2022. 26 funds tracked by Wall St. Rank hold NKGNW as of Q4 2024.

Fort Baker Capital Management reported no remaining NKGen Biotech, Inc. Warrants position as of Q4 2024 after selling out during the quarter.
Fort Baker Capital Management sold 36,934 NKGen Biotech, Inc. Warrants shares in Q4 2024, an estimated $2.61K.
Fort Baker Capital Management first reported a position in NKGen Biotech, Inc. Warrants in Q1 2022 and held it in 10 quarters.
Fort Baker Capital Management's NKGen Biotech, Inc. Warrants position peaked at $537K in Q1 2022.
26 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q4 2024.

Based on Fort Baker Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.